SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Christopher Moylen who wrote (90)1/20/1997 9:09:00 PM
From: Josh C. Pleasure, M.D.   of 371
 
Here's a copy of a post I just made to the Motley Fool message board:

I spoke to an Oncologist today. This was NOT your typical oncologist. He was very up-to-date with the medical literature, works at a small catholic hospital, but used to work at one of the top cancer hospitals in the U.S. He had referred several patients to the original IMMU-4 (CEA-Scan) study, so he is very familiar with Tc-FAB' imaging.

I asked his opinion of CEA-Scan. He said he is very impressed. Not exaggerating. In addition to ordering the test for his patients with colorectal ca, he stated that he sees great potential for CEA-Scan with breast cancer (as anyone who's read my report on IMMU would know already). He actually USES IT FOR HIS BREAST CANCER PATIENTS even though it's not approved for that application.

Also, he has been sending lymphoma patients (3 so far) over to the teaching hospital where Phase III trials of Lymphoscan are taking place. See my report for more details on Lymphoscan.

RE: buyout. I have stated in the past that both Berlex and Mallinckrodt are rumored to be interested in purchasing IMMU.

I was very happy when this oncologist gave me his glowing opinion of CEA-Scan. Remember, this guy is very knowledgeable and reads all the journals. He is the exception. But, he is one of a group of about 10 oncologists. The other 9 will learn by his example. This grape-vining is how cognizance and utilization of CEA-Scan will grow. Don't blame Mallinckrodt - this word of mouth action is much more powerful. Drug representatives are good for one thing: Free Lunch. Rarely do physicians listen to or act on what they say.

Buy all the IMMU you can...looks to me like CEA-Scan is going to be a success. And you already know what I think of LeukoScan.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News